Amelogenin: X CSF1PO:11,12D13S317:11D16S539:11,12D5S818:12,13D7S820: 8,12 THO1: 6,9.3 TPOX: 8 vWA:14,17
保藏机构
ATCC; CRL-1873
备注
该细胞为悬浮细胞,请注意离心收集细胞悬液,请勿直接倒掉细胞培养液。
Combination of PD-L1 positive TILs and SII could further refine prognosis in GCTs.An important aspect of malignant progression is the acquired ability of tumor cells to avoid recognition and destruction by the immune system (immune escape). Clinical cancer progression is also associated with the development of tumor hypoxia, which is mechanistically linked to the